Pediapharm Inc. (CVE:PDP – Get Free Report) was up 1.7% during mid-day trading on Thursday . The company traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares traded hands during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Performance
The firm’s fifty day simple moving average is C$0.30 and its 200 day simple moving average is C$0.30. The company has a market capitalization of C$66.36 million and a PE ratio of -4.11. The company has a debt-to-equity ratio of 186.87, a current ratio of 1.12 and a quick ratio of 0.71.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Further Reading
- Five stocks we like better than Pediapharm
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Consumer Discretionary Stocks Explained
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
